Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells

References

• Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193. doi:10.3322/caac.2139528248415
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490–1502. doi:10.1016/S0140-6736(13)61649-924225001
   PubMed Web of Science ®Google Scholar
• Sugihara K. Overview of treatment strategy of Stage IV colorectal cancer. Nihon Shokakibyo Gakkai Zasshi. 2017;114:1195–1200. doi:10.11405/nisshoshi.114.119528679976
   PubMedGoogle Scholar
• Salonga D, Danenberg KD, Johnson M, et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res. 2000;6:1322–1327.10778957
   PubMed Web of Science ®Google Scholar
• Peinert S, Grothe W, Stein A, et al. Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer. Ther Adv Med Oncol. 2010;2:161–174. doi:10.1177/175883401036506121789132
   PubMedGoogle Scholar
• Tomicic MT, Kaina B. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors. Biochim Biophys Acta. 2013;1835:11–27. doi:10.1016/j.bbcan.2012.09.00223006513
   PubMed Web of Science ®Google Scholar
• Britten RA, Kuny S, Perdue S. Modification of non-conservative double-strand break (DSB) rejoining activity after the induction of cisplatin resistance in human tumour cells. Br J Cancer. 1999;79:843–849. doi:10.1038/sj.bjc.669013510070879
   PubMed Web of Science ®Google Scholar
• Bennett CB, Lewis AL, Baldwin KK, Resnick MA. Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid. Proc Natl Acad Sci U S A. 1993;90:5613–5617. doi:10.1073/pnas.90.12.56138516308
   PubMed Web of Science ®Google Scholar
• Kim JS, Krasieva TB, Kurumizaka H, Chen DJ, Taylor AMR, Yokomori K. Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. J Cell Biol. 2005;170:341–347. doi:10.1083/jcb.20041108316061690
   PubMed Web of Science ®Google Scholar
• Kakarougkas A, Jeggo PA. DNA DSB repair pathway choice: an orchestrated handover mechanism. Br J Radiol. 2014;87:20130685. doi:10.1259/bjr.2013068524363387
   PubMed Web of Science ®Google Scholar
• Arnoult N, Correia A, Ma J, et al. Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN. Nature. 2017;549:548–552. doi:10.1038/nature2402328959974
   PubMed Web of Science ®Google Scholar
• San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008;77:229–257. doi:10.1146/annurev.biochem.77.061306.12525518275380
   PubMed Web of Science ®Google Scholar
• Gottlieb TM, Jackson SP. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell. 1993;72:131–142. doi:10.1016/0092-8674(93)90057-w8422676
   PubMed Web of Science ®Google Scholar
• Britton S, Coates J, Jackson SP. A new method for high-resolution imaging of Ku foci to decipher mechanisms of DNA double-strand break repair. J Cell Biol. 2013;202:579–595. doi:10.1083/jcb.20130307323897892
   PubMed Web of Science ®Google Scholar
• Riballo E, Kühne M, Rief N, et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol Cell. 2004;16:715–724. doi:10.1016/j.molcel.2004.10.02915574327
   PubMed Web of Science ®Google Scholar
• Bahmed K, Seth A, Nitiss KC, Nitiss JL. End-processing during non-homologous end-joining: a role for exonuclease 1. Nucleic Acids Res. 2011;39:970–978. doi:10.1093/nar/gkq88620935051
   PubMed Web of Science ®Google Scholar
• Li J, Summerlin M, Nitiss KC, Nitiss JL, Hanakahi LA. TDP1 is required for efficient non-homologous end joining in human cells. DNA Repair (Amst). 2017;60:40–49. doi:10.1016/j.dnarep.2017.10.00329078113
   PubMed Web of Science ®Google Scholar
• Heo J, Li J, Summerlin M, et al. TDP1 promotes assembly of non-homologous end joining protein complexes on DNA. DNA Repair (Amst). 2015;30:28–37. doi:10.1016/j.dnarep.2015.03.00325841101
   PubMed Web of Science ®Google Scholar
• Symington LS, Gautier J. Double-strand break end resection and repair pathway choice. Annu Rev Genet. 2011;45:247–271. doi:10.1146/annurev-genet-110410-13243521910633
   PubMed Web of Science ®Google Scholar
• Johnson RD, Jasin M. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. Embo J. 2000;19:3398–3407. doi:10.1093/emboj/19.13.339810880452
   PubMed Web of Science ®Google Scholar
• Aylon Y, Liefshitz B, Kupiec M. The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle. Embo J. 2004;23:4868–4875. doi:10.1038/sj.emboj.760046915549137
   PubMed Web of Science ®Google Scholar
• Liu Z, Yu M, Fei B, Sun J, Wang D. Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer. Onco Targets Ther. 2019;12:2095–2104. doi:10.2147/OTT.S19292330936724
   PubMed Web of Science ®Google Scholar
• Charoenrungruang S, Chanvorachote P, Sritularak B, Pongrakhananon V. Gigantol, a bibenzyl from Dendrobium draconis, inhibits the migratory behavior of non-small cell lung cancer cells. J Nat Prod. 2014;77:1359–1366. doi:10.1021/np500015v24844664
   PubMed Web of Science ®Google Scholar
• Bhummaphan N, Chanvorachote P. Gigantol suppresses cancer stem cell-like phenotypes in lung cancer cells. Evid Based Complement Alternat Med. 2015;2015:836564. doi:10.1155/2015/83656426339272
   PubMed Web of Science ®Google Scholar
• Unahabhokha T, Chanvorachote P, Pongrakhananon V. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells. Tumour Biol. 2016;37:8633–8641. doi:10.1007/s13277-015-4717-z26733180
   PubMedGoogle Scholar
• Chen H, Huang Y, Huang J, Lin L, Wei G. Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-kappaB signaling pathway. Oncol Rep. 2017;37:865–870. doi:10.3892/or.2016.529927959444
   PubMed Web of Science ®Google Scholar
• Li Y, Chirgadze DY, Bolanos-Garcia VM, et al. Crystal structure of human XLF/Cernunnos reveals unexpected differences from XRCC4 with implications for NHEJ. Embo J. 2008;27:290–300. doi:10.1038/sj.emboj.760194218046455
   PubMed Web of Science ®Google Scholar
• Meng Y, Chen C-W, Yung MMH, et al. DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer. Cancer Lett. 2018;428:104–116. doi:10.1016/j.canlet.2018.04.02929704517
   PubMed Web of Science ®Google Scholar
• Unahabhokha T, Chanvorachote P, Sritularak B, Kitsongsermthon J, Pongrakhananon V. Gigantol inhibits epithelial to mesenchymal process in human lung cancer cells. Evid Based Complement Alternat Med. 2016;2016:4561674. doi:10.1155/2016/504052827651818
   PubMed Web of Science ®Google Scholar
• Seluanov A, Mao Z, Gorbunova V. Analysis of DNA double-strand break (DSB) repair in mammalian cells. J Vis Exp. 2010. doi:10.3791/2002
   Google Scholar
• Andres SN, Modesti M, Tsai CJ, Chu G, Junop MS. Crystal structure of human XLF: a twist in nonhomologous DNA end-joining. Mol Cell. 2007;28:1093–1101. doi:10.1016/j.molcel.2007.10.02418158905
   PubMed Web of Science ®Google Scholar
• Hammel M, Rey M, Yu Y, et al. XRCC4 protein interactions with XRCC4-like factor (XLF) create an extended grooved scaffold for DNA ligation and double strand break repair. J Biol Chem. 2011;286:32638–32650. doi:10.1074/jbc.M111.27264121775435
   PubMed Web of Science ®Google Scholar
• Ochi T, Blackford AN, Coates J, et al. DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair. Science. 2015;347:185–188. doi:10.1126/science.126197125574025
   PubMed Web of Science ®Google Scholar
• Thacker J, Zdzienicka MZ. The mammalian XRCC genes: their roles in DNA repair and genetic stability. DNA Repair (Amst). 2003;2:655–672.12767346
   PubMed Web of Science ®Google Scholar
• Jensen NF, Stenvang J, Beck MK, et al. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: towards a predictive signature of chemoresistance. Mol Oncol. 2015;9:1169–1185. doi:10.1016/j.molonc.2015.02.00825759163
   PubMed Web of Science ®Google Scholar
• Wu J, Li X, Wan W, et al. Gigantol from Dendrobium chrysotoxum Lindl. binds and inhibits aldose reductase gene to exert its anti-cataract activity: an in vitro mechanistic study. J Ethnopharmacol. 2017;198:255–261. doi:10.1016/j.jep.2017.01.02628104409
   PubMed Web of Science ®Google Scholar
• Wu J, Li X, Fang H, et al. Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract. BMC Complement Altern Med. 2016;16:286. doi:10.1186/s12906-016-1251-527520089
   PubMed Web of Science ®Google Scholar
• Nakamura H, Yu-Qin W, Miyauchi S, et al [Studies on the mechanism of antitumor activity of 5-FU and its derivatives–relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo]. Gan To Kagaku Ryoho. 1984;11:1049–1055.6426401
   PubMedGoogle Scholar
• Raymond E, Faivre S, Woynarowski JM, Chaney SG. Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol. 1998;25:4–12.
   PubMed Web of Science ®Google Scholar
• Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol. 2018;24:3834–3848. doi:10.3748/wjg.v24.i34.383430228778
   PubMed Web of Science ®Google Scholar
• Yajima H, Lee KJ, Zhang S, Kobayashi J, Chen BP. DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases. J Mol Biol. 2009;385:800–810. doi:10.1016/j.jmb.2008.11.03619071136
   PubMed Web of Science ®Google Scholar
• Ho EL, Parent M, Satoh MS. Induction of base damages representing a high risk site for double-strand DNA break formation in genomic DNA by exposure of cells to DNA damaging agents. J Biol Chem. 2007;282:21913–21923. doi:10.1074/jbc.M61065120017545165
   PubMed Web of Science ®Google Scholar
• MacLean HE, Favaloro JM, Warne GL, Zajac JD. Double-strand DNA break repair with replication slippage on two strands: a novel mechanism of deletion formation. Hum Mutat. 2006;27:483–489. doi:10.1002/humu.2032716619235
   PubMed Web of Science ®Google Scholar
• Nowosielska A, Marinus MG. Cisplatin induces DNA double-strand break formation in Escherichia coli dam mutants. DNA Repair (Amst). 2005;4:773–781. doi:10.1016/j.dnarep.2005.03.00615925551
   PubMed Web of Science ®Google Scholar